AVTX · ISSUER CIK 1534120
Avalo Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Avalo Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $1.9M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 6 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.9MInsider selling
−$1.9MNet open-market
Sep 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202616:10 | Sep 16, 2026 | AVTX | Chief Financial Officer | S · Sell10b5-1 | $16.33 | −12,394 | 39,900 | -24% | −$202K | ||
| Sep 18, 202616:10 | Sep 16, 2026 | AVTX | Chief Financial Officer | M · Exercise10b5-1 | $9.88 | +12,394 | 52,294 | +31% | $122K | ||
| Sep 11, 202616:10 | Sep 10, 2026 | AVTX | Chief Financial Officer | S · Sell10b5-1 | $17.62 | −10,185 | 39,900 | -20% | −$179K | ||
| Sep 11, 202616:10 | Sep 10, 2026 | AVTX | Chief Financial Officer | M · Exercise10b5-1 | $8.04 | +10,185 | 50,085 | +26% | $82K | ||
| Sep 1, 202616:38 | Aug 28, 2026 | AVTX | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −679 | 51,776 | -1% | −$14K | ||
| Sep 1, 202616:38 | Aug 28, 2026 | AVTX | Chief Medical Officer | M · Exercise10b5-1 | $8.04 | +679 | 52,455 | +1% | $5K | ||
| Aug 19, 202616:10 | Aug 18, 2026from Aug 17, 2026 | AVTX | Chief Financial Officer | S · Sell10b5-1 | $19.94 | −72,725 | 39,900 | -65% | −$1.5M | ||
| Aug 19, 202616:10 | Aug 18, 2026from Aug 17, 2026 | AVTX | Chief Financial Officer | M · Exercise10b5-1 | $9.88 | +71,852 | 70,931 | — | $710K | ||
| Aug 19, 202616:10 | Aug 17, 2026 | AVTX | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −1,000 | 51,776 | -2% | −$20K | ||
| Aug 19, 202616:10 | Aug 17, 2026 | AVTX | Chief Medical Officer | M · Exercise10b5-1 | $12.65 | +1,000 | 52,776 | +2% | $13K | ||
| Aug 12, 202616:10 | Aug 11, 2026 | AVTX | Chief Strategy Officer | S · Sell | $19.59 | −2,655 | 37,041 | -7% | −$52K | ||
| Aug 12, 202616:10 | Aug 10, 2026 | AVTX | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −679 | 51,776 | -1% | −$14K | ||
| Aug 12, 202616:10 | Aug 10, 2026 | AVTX | Chief Medical Officer | M · Exercise10b5-1 | $8.04 | +679 | 52,455 | +1% | $5K |